TI
BRLI

Trexquant Investment’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Trexquant Investment’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,300
Closed -$395K – 1359
2014
Q4 		$395K Buy
+12,300
New +$356K 0.07% 566

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trexquant Investment's BRLI Position: Q1 2015 in Review

Trexquant Investment sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2015, closing a stake of 12,300 shares — an estimated $395K sold.

Trexquant Investment first reported a position in BRLI in Q4 2014 and held it in 1 quarter. The position peaked at $395K in Q4 2014. 168 funds tracked by Wall St. Rank hold BRLI as of Q1 2015.

  • Trexquant Investment reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2015 after selling out during the quarter.
  • Trexquant Investment sold 12,300 BIO-REFERENCE LABS INC-NEW- shares in Q1 2015, an estimated $395K.
  • Trexquant Investment first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2014 and held it in 1 quarter.
  • Trexquant Investment's BIO-REFERENCE LABS INC-NEW- position peaked at $395K in Q4 2014.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2015.

Based on Trexquant Investment's 13F filing for Q1 2015, filed 13 May 2015.